SCHEMBL6029205

SCHEMBL6029205

CC1NC(CO)=NN1c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 16/20 0.44
▸ MEN1 O00255 15/20 0.44
▸ ALDH1A1 P00352 15/20 0.44
▸ HPGD P15428 15/20 0.44
▸ KMT2A Q03164 15/20 0.44
▸ GLA P06280 14/20 0.44
▸ GAA P10253 8/20 0.44
▸ TDP1 Q9NUW8 12/20 0.40
▸ L3MBTL1 Q9Y468 8/20 0.40
▸ ATM Q13315 1/20 0.40
▸ PRKCZ Q05513 1/20 0.35
▸ ALOX12 P18054 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6029209 1.00 MAPT (0.44) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL13799718 0.75 LOX (0.40) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL25379636 0.60 MAPT (0.45) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL20112991 0.60 PRKCZ (0.41) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL13387492 0.57 MAPT (0.47) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL14367852 0.57 MEN1 (0.66) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL23864906 0.57 MAPK1 (0.38) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL5180030 0.56 LOX (0.46) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL7721905 0.56 L3MBTL1 (0.40) MAPTMEN1ALDH1A1HPGDKMT2A
Hydrochloric Acid SCHEMBL11038033 0.56 ALDH1A1 (0.37) MAPTMEN1ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1706396-A1 N-(4-CARBAMIMIDOYL-BENZYL)-2-ALKOXY-2-HETEROCYCLYL ACETAMIDES AS INHIBITORS OF THE FORMATION OF COAGULATION FACTORS XA, IXA AND THROMBIN INDUCED BY FACTOR VIIA F.HOFFMANN-LA ROCHE AG (CH) 2006-10-04 — — EP disclosed
US-7056932-B2 Heterocyclyl substituted 1-alkoxy acetic acid amides HOFFMAN-LA ROCHE INC. (US) 2006-06-06 — — US disclosed
WO-2005058868-A1 N-(4-CARBAMIMIDOYL-BENZYL) -2-ALKOXY-2-HETEROCYCLYL ACETAMIDES AS INHIBITORS OF THE FORMATION OF COAGULATION FACTORS XA, IXA AND THROMBIN INDUCED BY FACTOR VIIA F. HOFFMANN-LA ROCHE AG (CH) 2005-06-30 — — WO disclosed
US-20050137168-A1 Heterocyclyl substituted 1-alkoxy acetic acid amides HOFFMANN-LA ROCHE INC. 2005-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137168-A1 Heterocyclyl substituted 1-alkoxy acetic acid amides F12, TFPI, F11 MAPT 4778/4885MEN1 800/4885ALDH1A1 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback